Dynavax Technologies Corporation (NASDAQ:DVAX) reached a new 52-week high of $15.50 during today's trading session.
The Healthcare stock has gained 0.0% year-to-date and 0.0% over the past week. The previous 52-week high was $15.73.
Dynavax Technologies Corporation has a market capitalization of $1.3B. The stock's 52-week low was $9.20.
Reaching a 52-week high often signals strong momentum and investor confidence in Dynavax Technologies Corporation. Stocks at new highs can continue trending higher as breakout buying kicks in, though they also face increased selling pressure from profit-taking. The key question is whether fundamentals support the elevated valuation.
Today's trading volume of 5,659,539 shares is 3.4x the average daily volume, indicating significantly elevated interest. Moves on heavy volume are generally considered more meaningful than those on light volume, as they reflect broader participation.
Dynavax Technologies Corporation currently trades at $15.50, positioning the stock at the 96th percentile of its 52-week range ($9.20 — $15.73). This range context helps investors assess whether the stock is trading near support, resistance, or fair value relative to its recent history.